Procaps Group S.A. (NASDAQ:PROC) Short Interest Down 18.4% in December

Procaps Group S.A. (NASDAQ:PROC) was the recipient of a significant drop in short interest in December. As of December 31st, there was short interest totalling 133,300 shares, a drop of 18.4% from the December 15th total of 163,300 shares. Based on an average daily volume of 98,600 shares, the days-to-cover ratio is presently 1.4 days. Approximately 0.1% of the company’s stock are sold short.

Procaps Group Price Performance

NASDAQ:PROC opened at $1.75 on Friday. The firm has a fifty day simple moving average of $1.85 and a 200 day simple moving average of $2.01. Procaps Group has a 1-year low of $0.50 and a 1-year high of $4.50.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.